Inventor
ARRINGTON KENNETH L
US20 patents
⚠️ This page may combine multiple inventors who share the name “ARRINGTON KENNETH L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
11 patentsUS6306874B1Oct 23, 2001
Tyrosine kinase inhibitors
MERCK & CO INC214 citations99
US6794393B1Sep 21, 2004
Tyrosine kinase inhibitors
MERCK & CO INC75 citations98
US6927293B2Aug 9, 2005
Tyrosine kinase inhibitors
MERCK & CO INC69 citations97
US7501435B2Mar 10, 2009
Inhibitors of checkpoint kinases
MERCK & CO INC8 citations82
US7169788B2Jan 30, 2007
Tyrosine kinase inhibitors
MERCK & CO INC2 citations63
US7101884B2Sep 5, 2006
Tyrosine kinase inhibitors
MERCK & CO INC6 citations62
US7625912B2Dec 1, 2009
Mitotic kinesin inhibitors
MERCK & CO INC0 citations42
US7301028B2Nov 27, 2007
Mitotic kinesin inhibitors
MERCK & CO INC0 citations42
US7348440B2Mar 25, 2008
Mitotic kinesin inhibitors
MERCK & CO INC0 citations41
US7186723B2Mar 6, 2007
Tyrosine kinase inhibitors
MERCK & CO INC0 citations39
US7109204B2Sep 19, 2006
Tyrosine kinase inhibitors
MERCK & CO INC0 citations38
MERCK SHARP & DOHME
4 patentsUS10189831B2Jan 29, 2019
Non-nucleoside reverse transcriptase inhibitors
MERCK SHARP & DOHME75 citations96
US9499534B2Nov 22, 2016
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
MERCK SHARP & DOHME1 citations50
US9718819B2Aug 1, 2017
Non-nucleoside reverse transcriptase inhibitors
MERCK SHARP & DOHME1 citations49
US9598405B2Mar 21, 2017
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
MERCK SHARP & DOHME0 citations40